Strategic Genome Reserve Governance

Introduction

Strategic Genome Reserve Governance refers to the legal and institutional framework for collecting, storing, protecting, managing and using genomic information for national purposes such as public-health planning, disease surveillance, biomedical research, personalised medicine and preparedness for future biological emergencies. A genome reserve may include DNA samples, genomic sequences, biological specimens and associated health information maintained in secure national or institutional repositories.

Unlike an ordinary biological reserve, a genome reserve contains highly sensitive personal information. Therefore, its governance must balance scientific progress and national preparedness with privacy, informed consent, equality, data security and individual autonomy. In India, this subject is governed through constitutional principles, data-protection legislation, biomedical research guidelines and laws regulating biological materials.

1. Constitutional and Legal Framework in India

Article 21 of the Constitution protects life, personal liberty and the right to privacy. The collection and storage of an individual's genetic information must therefore satisfy legality, necessity and proportionality. Article 14 also requires non-arbitrary treatment, while Article 19 may become relevant where genomic information affects freedom of expression, research or professional activity.

The Digital Personal Data Protection Act, 2023 establishes a framework for processing digital personal data, including applicable obligations relating to consent, lawful processing, security safeguards and individual rights. Its application depends on the nature of the data and the relevant statutory provisions and exemptions.

The Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 provide ethical standards for research involving human biological materials and genetic information. They address informed consent, confidentiality, research ethics committee review, data protection and responsible use of biological samples.

The Biological Diversity Act, 2002 may also become relevant where biological resources, access, research or benefit-sharing obligations fall within its scope. These laws and guidelines together provide important safeguards for genomic repositories.

2. Objectives of Strategic Genome Reserves

The principal objectives include:

Preserving genomic information for long-term scientific research.

Supporting the identification of genetic risk factors and inherited diseases.

Improving preparedness for epidemics and emerging biological threats.

Promoting the development of personalised medicines and targeted therapies.

Supporting research into rare diseases and population-level genetic diversity.

Ensuring responsible access to genomic resources for public-health purposes.

However, national scientific objectives cannot automatically justify unlimited collection or use of personal genetic information.

3. Informed Consent and Individual Autonomy

Informed consent is a central requirement of ethical genome reserve governance. Participants should receive clear information about the purpose of collection, storage duration, possible future research, data-sharing arrangements, commercial use and risks of re-identification.

Broad consent may be appropriate for certain future research activities when permitted by applicable ethical and legal standards, but it should not be treated as unrestricted permission for every future use. Researchers must also establish procedures for withdrawal of consent, subject to lawful limitations and the practical consequences of anonymisation or completed research.

4. Privacy, Confidentiality and Data Security

Genomic information is particularly sensitive because it may reveal inherited characteristics and information about biological relatives. Even when names are removed, genetic data may sometimes be re-identified by combining it with other datasets.

Governance should therefore include encryption, access controls, secure storage, audit trails, restrictions on data transfers, breach-response procedures and independent oversight. Discriminatory use by employers, insurers or other organisations must also be addressed through appropriate legal safeguards.

5. Public Interest, National Security and Controlled Access

A strategic genome reserve may support disease surveillance, epidemiological research and emergency response. However, access should be based on defined legal purposes and not on unrestricted government discretion. An independent governing authority should supervise collection, storage, access, sharing and destruction of samples.

Access may be permitted to approved researchers, public-health institutions and authorised laboratories, subject to ethics approval and data-security conditions. Any exceptional access without individual consent should have a clear legal basis, a legitimate public purpose and safeguards against excessive use.

6. Benefit-Sharing and Protection of Communities

Genome research may generate commercial products, diagnostic technologies and pharmaceutical discoveries. Governance should address whether participants and communities whose biological samples contribute to such discoveries receive appropriate recognition or benefits.

The Biological Diversity Act, 2002 provides an access-and-benefit-sharing framework for biological resources and associated traditional knowledge. The National Biodiversity Authority and State Biodiversity Boards perform regulatory functions under the Act. However, the Act should not automatically be treated as a comprehensive law governing every human genomic sample. Its application depends on the resource, activity and statutory definitions involved.

India Code+2

7. Important Case Laws

(a) Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21. It explained that State interference with privacy must satisfy legality, legitimate State purpose and proportionality. This judgment is central to genome reserve governance because collecting and retaining genetic information can affect informational privacy and personal autonomy.

Indian Kanoon

(b) K.S. Puttaswamy v. Union of India (2019) 1 SCC 1 (Aadhaar judgment)

The Supreme Court examined the constitutional validity of the Aadhaar framework, including the collection and use of biometric information. Its reasoning on necessity, proportionality, data protection and limits on information use is relevant by analogy to a national genomic database. Biometric identity data and genomic information are not identical, but both raise concerns about large-scale personal-data collection.

(c) Selvi v. State of Karnataka (2010) 7 SCC 263

The Supreme Court held that involuntary narco-analysis, polygraph and brain-mapping tests violate constitutional protections, including personal liberty and the right against compelled self-incrimination in the circumstances considered. The decision supports the principle that sensitive biological or cognitive information should not be extracted through coercion.

(d) Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court explained the requirements of valid medical consent, including adequate information and voluntary authorisation for the proposed procedure. The judgment is relevant to obtaining consent before collecting biological samples for genomic research or future storage.

(e) Divya Pharmacy v. Union of India (2018) (Uttarakhand High Court)

The Court considered benefit-sharing obligations under the Biological Diversity Act in relation to commercial use of biological resources. Its reasoning is relevant to discussions about equitable sharing of benefits arising from biological-resource research, although it was not a case about human genome reserves.

8. Challenges in Strategic Genome Reserve Governance

Several legal and ethical challenges may arise:

Data misuse: Genetic information may be used for unauthorised profiling, discrimination or surveillance.

Re-identification: Removing names from genomic records does not always prevent identification.

Consent disputes: Participants may disagree with secondary research or commercial use of stored samples.

Cross-border transfer: International sharing may create questions of jurisdiction, confidentiality and benefit-sharing.

Community rights: Research involving indigenous or vulnerable populations requires particular attention to collective interests and equitable benefits.

Institutional accountability: Clear responsibility is necessary for data breaches, unauthorised access, improper storage and misuse of samples.

The ICMR National Ethical Guidelines, 2017 specifically address biobanking, biological materials, datasets, repository governance, donor protection and contingency planning. They provide an important ethical foundation, although they are not a substitute for comprehensive legislation specifically regulating genomic reserves.

ICMR STS+1

Conclusion

Strategic Genome Reserve Governance is an emerging area of biotechnology and constitutional law. It can strengthen scientific research, public-health preparedness and medical innovation, but it also creates serious questions concerning privacy, informed consent, equality, data security and ownership of biological materials. In India, the constitutional principles recognised in Puttaswamy, the ethical standards issued by ICMR and the relevant provisions of the Digital Personal Data Protection Act, 2023 and Biological Diversity Act, 2002 provide parts of the governing framework.

There is no established Supreme Court judgment specifically creating a legal framework for a national strategic human genome reserve. The cases discussed above therefore provide relevant constitutional and ethical principles by analogy rather than direct rulings on genome-reserve administration. A dedicated statutory framework, independent oversight, transparent access rules and effective benefit-sharing mechanisms would help ensure that genomic resources are used responsibly and in the public interest.